Both in Pharmaceuticals
Skye Bioscience vs Acurx Pharmaceuticals
Over the past year SKYE returned −89.7% and ACXP returned −79.3%; their daily moves had a correlation of 0.04.
SKYE −89.7% ACXP −79.3%Growth of $1, one year, split-adjusted
| Metric | SKYE | ACXP |
|---|---|---|
| Price | $1.28 | $1.04 |
| Market cap | $5.7M | $5.7M |
| Today | −2.29% | −2.80% |
| 1 month | −20.0% | −17.5% |
| 6 months | −80.6% | −51.9% |
| Year to date | −78.7% | −58.2% |
| 1 year | −89.9% | −81.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.9M | $10.7M |
| Dividend yield | — | — |
| Volatility (60d) | 616.8% | 60.2% |
| Short % of float | 0.6% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).